ABIOMED

График котировок ABIOMED


Добавить в список сравнения
Добавить в список отслеживания

Основные параметры

Цена ао 277.47
P/E 75.42
P/S 15.02
P/BV 10.73
EV/EBITDA 46.69
EBITDA 244.88

Основные владельцы

Institutions Объем Доля, %
First Trust Portfolios L.P. 36684 0.08
Advisors Asset Management, Inc. 3300 0.01
Invesco Capital Markets Inc 9 0
Standard & Poors Inv Advisory Srvc LLC 8 0
Nationwide Fund Advisors 182281 0.4
Baillie Gifford Overseas Limited 45937 0.1
Janus Capital Management LLC 15958 0.04
Dorsey Wright & Associates LLC 3051 0.01
Peroni Portfolio Advisors, Inc 300 0
Palo Alto Investors, LLC 502745 1.11
Alaia Capital, LLC 400 0
BlackRock Fund Advisors 1687669 3.72
Credit Suisse Asset Management (Schweiz) AG 652182 1.44
Argenta Asset Management S.A. 79054 0.17
St. Denis J. Villere & Company, LLC 10400 0.02
Hartford Funds Management Company, LLC 689422 1.52
MML Investment Advisers, LLC 81042 0.18
Invesco Capital Management LLC 269055 0.59
Scotia Fondos SA de CV 10150 0.02
SunAmerica Asset Management, LLC 239483 0.53

Похожие компании

Описание ABIOMED

Abiomed is a manufacturer of medical implant devices, including the AbioCor artificial heart and Impella. It is headquartered in Danvers, Massachusetts and has three additional offices, two in Germany in the cities of Berlin and Aachen, and another in Japan. Michael R. Minogue joined Abiomed in 2004, and serves as CEO, Chairman and President.